表 3. Clinical outcomes of patients with ANVUGIB.
ANVUGIB患者临床结局事件
| Variable | Dynamic elevated
BUN/Cr ratio group (n=16) |
Non-dynamic elevated
BUN/Cr ratio group (n=146) |
Test statistics | P |
| GIB: Gastrointestinal bleeding; BUN: Blood urea nitrogen; Cr: Creatinine. | ||||
| Primary clinical outcomes/case (%) | 11 (68.75) | 6 (4.11) | χ2=57.450 | <0.001 |
| Death for any reason | 1 (6.25) | 0 (0.00) | − | 0.099 |
| Recurrent GIB | 11 (68.75) | 5 (3.42) | χ2=61.988 | <0.001 |
| Emergency surgical therapy | 2 (12.50) | 0 (0.00) | − | 0.009 |
| Emergency interventional therapy | 2 (12.50) | 2 (1.37) | − | 0.049 |
| Secondary clinical outcomes | ||||
| Endoscopic therapy/case (%) | 4 (25.00) | 20 (13.70) | χ2=0.701 | 0.402 |
| Blood transfusion therapy/case (%) | 8 (50.00) | 55 (37.67) | χ2=0.922 | 0.337 |
| Length of stay/d | 16.75±15.93 | 7.64±4.46 | t=2.277 | 0.038 |